Stay updated on Secukinumab in AS: Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in AS: Clinical Trial page.

Latest updates to the Secukinumab in AS: Clinical Trial page
- Check7 days agoChange DetectedA site-wide NIH transition notice appears above the ClinicalTrials.gov 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study content with an access notice. This indicates an access restriction rather than an update to the study details or related information.SummaryDifference18%

- Check42 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6, which indicates an updated version of the page template or content management system.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6. This reflects a back-end or UI update and does not change the displayed study information on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page shows Revision: v3.6.5, indicating a small underlying update to the page template, with no changes to the study details or results.SummaryDifference0.0%

Stay in the know with updates to Secukinumab in AS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in AS: Clinical Trial page.